Ray-Jade Chen

Chairman
​Taipei Medical University
​
​​

Dr. Kang-Yun Lee is Professor of Internal medicine and Executive Vice President of Taipei Medical University (TMU). He headed the Asthma Assembly of Asian Pacific Society of Respirology (APSR) during 2020-2023. Dr. Lee qualified his first degree of Medicine at TMU and received a PhD in clinical pharmacology at Imperial College London in 2006.
 
Dr. Lee had been working on pathogenesis of asthma, COPD, and lung cancer. In addition to clinically orientated research, he has been working on molecular control of inflammation and immunity in lung diseases. He is interested in microenvironment and immune therapy for lung cancer. His lab identified a novel myeloid-derived suppressor cell (MDSC) in lung cancer, which has been implicated in tumor aggressiveness and drug resistance. Dr. Lee also participates in a great number of clinical trials, in variable lung diseases, including airways diseases, lung cancer and pneumonia.

 

Speech title & Synopsis

Reshaping the Future Healthcare with 「Gen」Medicine

 Dr. Ray-Jade Chen of Taipei Medical University explores the integration of genomics, data science, and generative AI as key drivers of future healthcare transformation. In response to global challenges such as aging populations and the increasing burden of chronic diseases, precision medicine—enabled by affordable whole-genome sequencing, gene therapies, and AI-driven drug innovation—offers promising solutions. Taiwan’s “Healthy Taiwan” initiative and TMU’s digital transformation strategies demonstrate national and institutional commitments to precision prevention and personalized care. Despite the great opportunities presented by generative AI, challenges related to data privacy, misinformation, and ethical governance must be addressed to ensure responsible integration. The convergence of genomics and AI thus heralds a new paradigm in equitable, efficient, and patient-centered healthcare delivery.